期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

纤溶酶原激活物抑制剂-1与肾间质纤维化 被引量：2

Plasminogen activator inhibitor and renal interstitial fibrosis
下载PDF
导出
摘要 肾间质纤维化(RIF)是各种慢性肾脏疾病发展到终末期肾病的共同归路。纤溶酶原激活物抑制剂(PAI)的表达及活性异常在RIF病变中发挥着至关重要的作用。该文就PAIs系统在RIF发生发展过程中的作用做一综述。 Renal interstitial fibrosis（RIF）is the final common pathway by which all kidney diseases progress to the end stage of renal disease. Present study confirmed that the expression and abnormal activity of plasminogen activator inhibitor （PAl）play a vital role in the development process of RIF. This is a review of the role of PAl in the development process of RIF.
作者 刘艳红 韩子明
机构地区 郑州人民医院新生儿科 新乡医学院第一临床医院儿内二科
出处 《中国临床新医学》 2011年第1期84-88,共5页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词 肾间质纤维化 纤溶酶原激活物 纤溶酶原激活物抑制剂-1 细胞外基质 Renal interstitial fibrosis Plasminogen activator inhibitor Extraeelluar matrix
分类号 R692 [医药卫生—泌尿科学]
  • 相关文献

参考文献27

  • 1Nangaku M. Mechanisms of tubulointerstitial injury in the kindney:final common pathways to end-stage renal failure [ J ]. Intern Med, 2004,43 ( 1 ) :9 - 17.
  • 2Razzaque MS, Taguchi L. Cellular and molecular events leading to renal mbulointerstifial fibrosis [ J ]. Med Electron Microse, 2002, 35 (2) :68 -80.
  • 3陈香美.凝血纤溶系统与细胞外基质调控系统在肾脏疾病中的作用[J].中华肾脏病杂志,2001,17(5):348-349. 被引量：61
  • 4Zhang G, Kim H, Cai X, et al. Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy [ J ]. J Am Soc Nephrol,2003, 14(5) :1254 - 1271.
  • 5Hertig A, Berrou J, Anory Y, et al. Type I plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overaetivafion of transforming growth factor beta [ J ]. FASEB J, 2003,17 ( 13 ) : 1904 - 1906.
  • 6Eddy AA. Plasminogen activator inhibitor-1 and the kidney [ J ]. Am J Physiol Renal Physiol, 2002, 283 (2) : F209 - 220.
  • 7Pontrelli P, Ranier E, Ursi M, et al. Jun-N-terminal kinas regulatesthrombin- induced PAId gene expression in proximal tubular epithelial cells[J]. Kidney Int, 2004,65(6) :2249 -2261.
  • 8Lassila M, Fukami K, Jandeleit-Dahm K, et al. Plasminogen activator inhibitor-1 production is pathogenetic in experimental routine diabetic renal disease [J]. Diabetologia,2007,50(6) :1315 - 1326.
  • 9He L, Qi Y, Rong X, et al. The ayurvedic medicine salaeia oblonga attenuates diabetic renal fibrosis in rats : suppression of angiotensin II / AT-1 signaling[J]. Evid Based Complement Altemat Med, 2009,25 [ Epub ahead of print].
  • 10Samarakoon R, Higgins CE, Higgins SP, ct al. TGF-betal-Induced Expression of the Poor Prognosis SERPINE1/PAI-1 Gene Requires EGFR Signaling: A New Target for Anti-EGFR Therapy[J]. J Oncol,2009, 9:342-391.

二级参考文献13

  • 1谌贻璞.炎症细胞与炎症介质[A].王海燕.肾脏病学.第2版[C].北京:人民卫生出版社,1996.477—478.
  • 2Ong AC, Jowett TP, Firth JD, et al. An endothelin-1 mediated autocrine growth loop involved in human renal tubular regeneration. Kidney Int, 1995, 48: 390-401.
  • 3Gomez-Garre D, Largo R, Liu XH, et al. An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis. Kidney Int, 1996, 50:962-972.
  • 4Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol, 1996, 7: 2495-2508.
  • 5Eickelberg O, Khler E, Reichenberger F, et al. Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-β1 and TGF-β3. Am J Physiol Lung Cell Mol Physiol, 1999, 276: 814-824.
  • 6Iwamoto T, Tamaki K, Nakayama M, et al. Effect of endothelin 1 on fibrinolysis and plasminogen activator inhibitor 1 synthesis in rat mesangial cells. Nephron 1996, 73:273-279.
  • 7Benigni A. Tubulointerstitial disease mediators of injury: the roles of endothelin. Nephrol Dial Transplant, 2000,15(Suppl 6): 50-52.
  • 8Kohan DE. Endothelins in the normal and diseased kidney. Am J Kidney Dis, 1997,29:2-26.
  • 9Feldman DL, Mogelesky TC, Chou M, et al. Enhanced expression of renal endothelin- converting enzyme-1 and endothelin-A-receptor mRNA in rats with interstitial fibrosis following ureter ligation. J Cardiovasc Pharmacol, 2000, 36(5 Suppl 1): S255-259.
  • 10Sharma AK, Mauer M, Kim Y, et al. Interstitial fibrosis in obstructive nephropathy. Kidney Int, 1993, 47: 774-788.

共引文献79

同被引文献20

引证文献2

二级引证文献11

中国临床新医学
2011年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部